HTG Molecular Diagnostics Inc News Releases http://investors.htgmolecular.com/ HTG Molecular Diagnostics Inc News Releases en HTG Molecular Diagnostics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) http://investors.htgmolecular.com/news-releases/news-release-details/htg-molecular-diagnostics-inc-reports-inducement-grants-under TUCSON, Ariz. , May 24, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced that on May 22, 2019 the Compensation Committee of its Board of Directors granted inducement stock options to Fri, 24 May 2019 16:05:00 -0400 HTG Molecular Diagnostics Inc News Releases 9566 HTG Molecular Diagnostics Reports First Quarter 2019 Results http://investors.htgmolecular.com/news-releases/news-release-details/htg-molecular-diagnostics-reports-first-quarter-2019-results Call scheduled for today, May 9, at 4:30pm ET TUCSON, Ariz. , May 09, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today reported its financial results for the first quarter ended March 31, 2019 Thu, 09 May 2019 16:05:00 -0400 HTG Molecular Diagnostics Inc News Releases 9536 HTG Molecular Diagnostics to Announce First Quarter 2019 Financial Results and Host Conference Call on Thursday, May 9 http://investors.htgmolecular.com/news-releases/news-release-details/htg-molecular-diagnostics-announce-first-quarter-2019-financial TUCSON, Ariz. , April 30, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will report its financial results for the first quarter ended March 31, 2019 after the market close on Tue, 30 Apr 2019 16:05:00 -0400 HTG Molecular Diagnostics Inc News Releases 9526 HTG Molecular Expands Agreement with Illumina to Include Autoimmune, Cardiovascular, and Fibrosis Disorders and Diseases http://investors.htgmolecular.com/news-releases/news-release-details/htg-molecular-expands-agreement-illumina-include-autoimmune Amendment allows for the development of IVD test kits compatible with Illumina technology TUCSON, Ariz. , April 30, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it has amended its Tue, 30 Apr 2019 08:00:00 -0400 HTG Molecular Diagnostics Inc News Releases 9521 HTG Introduces the HTG EdgeSeq Mouse mRNA Tumor Response Panel http://investors.htgmolecular.com/news-releases/news-release-details/htg-introduces-htg-edgeseq-mouse-mrna-tumor-response-panel TUCSON, Ariz. , March 27, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it has released a new HTG EdgeSeq Mouse mRNA Tumor Response Panel available now in the United States and Wed, 27 Mar 2019 16:05:00 -0400 HTG Molecular Diagnostics Inc News Releases 9486 HTG Molecular Diagnostics Reports Full Year 2018 Results http://investors.htgmolecular.com/news-releases/news-release-details/htg-molecular-diagnostics-reports-full-year-2018-results Revenue increased 46% in 2018 compared to the prior year reflecting continued success growing the company’s profiling business with Pharma company customers TUCSON, Ariz. , March 07, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM) (HTG), a life science company whose mission Thu, 07 Mar 2019 16:05:00 -0500 HTG Molecular Diagnostics Inc News Releases 9451 HTG Molecular Diagnostics to Announce Fourth Quarter and Fiscal Year Ended December 31, 2018 Financial Results and Host Conference Call on Thursday, March 7 http://investors.htgmolecular.com/news-releases/news-release-details/htg-molecular-diagnostics-announce-fourth-quarter-and-fiscal TUCSON, Ariz. , Feb. 21, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will report its financial results for the quarter and year ended December 31, 2018 after the market close Thu, 21 Feb 2019 16:05:00 -0500 HTG Molecular Diagnostics Inc News Releases 9441 HTG Molecular to Present Corporate Overview at the Cowen & Company 39th Annual Health Care Conference http://investors.htgmolecular.com/news-releases/news-release-details/htg-molecular-present-corporate-overview-cowen-company-39th TUCSON, Ariz. , Feb. 21, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that TJ Johnson, Chief Executive Officer, will present a corporate overview at the Cowen & Company 39th Thu, 21 Feb 2019 08:00:00 -0500 HTG Molecular Diagnostics Inc News Releases 9436 HTG Molecular Announces an Amendment and Extension to its Precision Diagnostic Partnership (PDP) Two http://investors.htgmolecular.com/news-releases/news-release-details/htg-molecular-announces-amendment-and-extension-its-precision TUCSON, Ariz. , Feb. 20, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it has amended its second precision diagnostic partnership program (“PDP Two”) with QIAGEN Manchester Limited Wed, 20 Feb 2019 16:01:00 -0500 HTG Molecular Diagnostics Inc News Releases 9426 HTG Molecular to Present Corporate Overview at the 8th Annual SVB Leerink Global Healthcare Conference http://investors.htgmolecular.com/news-releases/news-release-details/htg-molecular-present-corporate-overview-8th-annual-svb-leerink TUCSON, Ariz. , Feb. 20, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that TJ Johnson, Chief Executive Officer, will present a corporate overview the 8 th Annual SVB Leerink Wed, 20 Feb 2019 08:00:00 -0500 HTG Molecular Diagnostics Inc News Releases 9421